Latest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
PACE: A trial that challenges dogma
Posted Nov 24, 2009
at 01:50 PM, EDT
by Eric Topol
This well designed trial sought to find out whether placing a right ventricular lead at the apex--as per standard pacing procedure--leads to adverse cardiac remodeling and hence could promote heart failure and cardiac death. The results not only challenge dogma but pose a dilemma for clinical practice. How do you interpret the PACE trial? What are your thoughts?
See:
PACE: BiV pacing protects against RV pacing's adverse ventricular effects in randomized trial
Cheuk-Man Y, Yat-Sun Chan J, Zhang Q, et al. Biventricular pacing in patients with bradycardia and normal ejection fraction. N Engl J Med 2009; DOI: 10.1056/NEJMoa0907555. Available at: http://www.nejm.org.
Previous posts
Taking point-of-care genetic testing closer to mainstream
4 Comments |
Posted Apr 11, 2012
at 09:27 AM, EDT by Steven
at 09:27 AM, EDT by Steven
Statins and diabetes: A hard look at the data
43 Comments |
Posted Mar 01, 2012
at 05:25 PM, EDT by Eric
at 05:25 PM, EDT by Eric
Talking about a (healthcare) revolution: The digital age ushers in precision medicine
9 Comments |
Posted Jan 25, 2012
at 11:25 AM, EDT by Eric
at 11:25 AM, EDT by Eric
An important miscue in clopidogrel pharmacogenomics
13 Comments |
Posted Dec 27, 2011
at 04:00 PM, EDT by Eric
at 04:00 PM, EDT by Eric
Big-time progress in cardiovascular genomics
1 Comments |
Posted Oct 11, 2011
at 01:05 PM, EDT by Steven
at 01:05 PM, EDT by Steven
Also from theheart.org
Blogs I read
Who's talking
|
Eric J Topol MD
Director, Scripps Translational Science Institute The Gary and Mary West Chair of Innovative Medicine Chief Academic Officer, Scripps Health La Jolla, CA |














Comments
Dear Dr.Topol,
In our clinic ( 700 pacing device implantations annually ) like in most high volume centers RV apical pacing has been abandoned for many years. The alternative has been RV septal pacing which desynchronizes the electrical activation of the LV much less than RV apical pacing. Only the patients with LBBB, wide QRS and poor LV function really need bivenricular pacing. So patients with heart block and normal LV function can be managed with DDD RV septal pacing.
Best regards
Sami Pakarinen, MD
Helsinki University Central Hospital, Finland, Europe